ERTAHIL SIT 15/100MG TAB

ERTAHIL SIT 15/100MG is a combination tablet containing Ertugliflozin and Sitagliptin, designed to help manage type 2 diabetes mellitus. This dual-action formulation works by improving insulin sensitivity and regulating blood glucose levels through complementary mechanisms. Ertugliflozin, an SGLT2 inhibitor, helps the kidneys remove excess glucose through urine, while Sitagliptin, a DPP-4 inhibitor, enhances the body's natural insulin response. Together, they provide effective glycemic control in patients whose diabetes is not adequately managed with diet and exercise alone. Suitable for adults with type 2 diabetes, this medication may be used as monotherapy or in combination with other antidiabetic agents. Always follow your healthcare provider's dosage instructions and maintain regular monitoring of blood glucose levels during treatment.